BioRadar co-founder and President Nikki Romanik, MD, will moderate on the main stage at BIO International Convention 2026, taking place June 22–25 at the San Diego Convention Center. BIO International is the world’s largest biotechnology industry gathering, convening thousands of leaders from biopharma, biotech, government, public health, and academia to shape the future of life sciences. This year’s theme — “Driven by Purpose” — reflects a field increasingly focused on applying science to advance human health and societal resilience.

Dr. Romanik’s presence on the main stage is a recognition of the growing urgency around biological intelligence and early-threat detection. As a physician and public health leader, she brings rare credibility to conversations at the intersection of AI, biosurveillance, and pandemic preparedness — three of the defining focus areas at BIO 2026. Her work at BioRadar sits at the center of these themes: the company continuously monitors for emerging biological threats by fusing environmental metagenomics, syndromic hospital data, pharmacy utilization signals, and behavioral data into a single, community-specific intelligence picture.

BioRadar’s approach is threat-agnostic — built to detect known pathogens, new variants, unknown organisms, and engineered threats before they become crises. By establishing biological baselines at the community level, the platform is designed to catch deviations early, when intervention still matters.

BIO 2026 arrives as BioRadar accelerates its city-level pilots and deepens partnerships with public health agencies, health systems, and government bodies across the country. The company is building the biological intelligence infrastructure the United States needs — and this week in San Diego, that mission takes center stage.